Icaritin inhibits lung cancer-induced osteoclastogenesis by suppressing the expression of IL-6 and TNF-a and through AMPK/mTOR signaling pathway-Reference-Cited by-同舟云学术

Icaritin inhibits lung cancer-induced osteoclastogenesis by suppressing the expression of IL-6 and TNF-a and through AMPK/mTOR signaling pathway

Published:2020-07-20 Issue:10 Volume:31 Page:1004-1011
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Zhao Xueqiang,Lin Yun,Jiang Bijia,Yin Jianhua,Lu Chunlan,Wang Juan,Zeng Jinrong

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference36 articles.

1. Cancer treatment and survivorship statistics, 2019.;Miller;CA Cancer J Clin,2019

2. Bone metastasis target redox-responsive micell for the treatment of lung cancer bone metastasis and anti-bone resorption.;Ye;Artificial Cells Nanomedicine Biotechnology,2018

3. Predictors of survival in patients with bone metastasis of lung cancer.;Sugiura;Clin Orthop Relat Res,2008

4. Downregulation of CD24 suppresses bone metastasis of lung cancer.;Okabe;Cancer Sci,2018

5. The genus Epimedium: an ethnopharmacological and phytochemical review.;Ma;J Ethnopharmacol,2011

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bone marrow adipocytes and lung cancer bone metastasis: unraveling the role of adipokines in the tumor microenvironment;Frontiers in Oncology;2024-03-20

2. CPSF6-mediated XBP1 3’UTR shortening attenuates cisplatin-induced ER stress and elevates chemo-resistance in lung adenocarcinoma;Drug Resistance Updates;2023-05

3. Tumor Necrosis Factor-α Promotes the Tumorigenesis, Lymphangiogenesis, and Lymphatic Metastasis in Cervical Cancer via Activating VEGFC-Mediated AKT and ERK Pathways;Mediators of Inflammation;2023-04-21

4. Novel Anti-Cancer Products Targeting AMPK: Natural Herbal Medicine against Breast Cancer;Molecules;2023-01-11

5. How zoledronic acid improves osteoporosis by acting on osteoclasts;Frontiers in Pharmacology;2022-08-25